(1)
Bevacizumab Plus Chemotherapy As First-Line Treatment for Patients With Metastatic Colorectal Cancer: Results from a Spanish Observational Study. J. Anal. Oncol. 2013, 2 (3),  128-134. https://doi.org/10.6000/1927-7229.2013.02.03.1.